Bharangin, a Diterpenoid Quinonemethide, Abolishes Constitutive and Inducible Nuclear Factor-κB (NF-κB) Activation by Modifying p65 on Cysteine 38 Residue and Reducing Inhibitor of Nuclear Factor-κB α Kinase Activation, Leading to Suppression of NF-κB-Regulated Gene Expression and Sensitization of Tumor Cells to Chemotherapeutic Agents

Samankaltaisia teoksia

• NF-κB regulation: the nuclear response
  Tekijä: Mankan, Arun K, et al.
  Julkaistu: (2009)
• The Nuclear Factor NF-κB Pathway in Inflammation
  Tekijä: Lawrence, Toby
  Julkaistu: (2009)
• Atypical IκB proteins – nuclear modulators of NF-κB signaling
  Tekijä: Schuster, Marc, et al.
  Julkaistu: (2013)
• Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
  Tekijä: Zhou, Yifan, et al.
  Julkaistu: (2020)
• Modification of Cysteine 179 of IκBα Kinase by Nimbolide Leads to Down-regulation of NF-κB-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents
  Tekijä: Gupta, Subash C., et al.
  Julkaistu: (2010)